Latest Breaking News On - Alisona galbraith - Page 1 : vimarsana.com

email article You might think that when asthma patients were switched involuntarily from regular insurance to high-deductible health plans (HDHPs), a substantial number would cut corners on their daily controller medications but you would mostly be wrong, researchers said. In fact, in a study of some 185,000 pediatric and adult patients with asthma spanning 2002 to 2014, average adherence (as measured by prescription refills and days covered by filled prescriptions) did not change markedly with such switches, reported Alison A. Galbraith, MD, PhD, of Harvard Medical School in Boston, and colleagues in A few comparisons did show minor but statistically significant differences. For example, adults switched to HDHPs who were using inhaled corticosteroids and long-acting beta agonist (ICS-LABA) controllers showed a 1.4% greater decrease in days covered compared with patients remaining in conventional plans (95% CI 0.3%-2.5%), though not in other adherence measures.

United statesMatthewm davisJennifer kusmaAlisona galbraithHarvard medical schoolLurie childrenஒன்றுபட்டது மாநிலங்களில்ஜெனிபர் குஸ்மாஹார்வர்ட் மருத்துவ பள்ளிலூரி குழந்தைகள்